Ingenia Therapeutics
Cambridge, US · Founded 2018 · Delaware corporation
Founders & leadership
MK
Minji KimExecutive
SH
Sangyeul HanExecutive
Reported raises · per SEC filings
Form D private placements$16.8M disclosed across 4 rounds · 2019–2024
▶$5MraisedJun 2024 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedJun 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sang Gyun KimDirector
- Eric FurfineDirector
- Joo Hee KwakDirector
- Sangyeul HanExecutive Officer, Director
- Kwang Ho CheongDirector
- Offering amount
- $25M
- Amount sold
- $5M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedNov 2022 · 5 investors · BiotechnologyRule 506(b)
▶$7MraisedNov 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sung Jae KimDirector
- Sangyeul HanExecutive Officer, Director
- Eric FurfineDirector
- Heewon ParkDirector
- Offering amount
- $16M
- Amount sold
- $7M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$4.7MraisedSep 2020 · 9 investors · BiotechnologyRule 506(b)
▶$4.7MraisedSep 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Minji KimExecutive Officer, Director
- Sangyeul HanExecutive Officer, Director
- Offering amount
- $5.7M
- Amount sold
- $4.7M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$100KraisedDec 2019 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedDec 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Minji KimDirector
- Sangyeul HanExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $100K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Ingenia Therapeutics raised?
- Ingenia Therapeutics has disclosed $16.8M raised across 4 rounds.
- Where is Ingenia Therapeutics headquartered?
- Ingenia Therapeutics is headquartered in Cambridge, US.